Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 184

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer

Open access
Wang, Dejie, Ding, Liya, Wang, Liguo, Zhao, Yu, Sun, Zhifu, Karnes, R. Jeffrey, Zhang, Jun, Huang, Haojie · 2015 · Oncotarget

Abstract

// Dejie Wang 1, 2, 3, * , Liya Ding 1, * , Liguo Wang 4 , Yu Zhao 1 , Zhifu Sun 4 , R. Jeffrey Karnes 2, 3 , Jun Zhang 5 , Haojie Huang 1, 2, 3 1 Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA 2 Department of Urology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA 3 Mayo Clinic Cancer Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA 4 Department of Medical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA 5 Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA * These authors have contributed equally to this work Correspondence to: Haojie Huang, e-mail: huang.haojie@mayo.edu Keywords: MALAT1, EZH2, castration-resistant prostate cancer (CRPC), Polycomb repressive complex 2 (PRC2) Received: April 10, 2015 Accepted: September 20, 2015 Published: October 15, 2015 ABSTRACT The Polycomb protein enhancer of zeste homolog 2 (EZH2) is frequently overexpressed in advanced human prostate cancer (PCa), especially in lethal castration-resistant prostate cancer (CRPC). However, the signaling pathways that regulate EZH2 functions in PCa remain incompletely defined. Using EZH2 antibody-based RNA immunoprecipitation-coupled high throughput sequencing (RIP-seq), we demonstrated that EZH2 binds to MALAT1 , a long non-coding RNA (lncRNA) that is overexpressed during PCa progression. GST pull-down and RIP assays demonstrated that the 3′ end of MALAT1 interacts with the N-terminal of EZH2. Knockdown of MALAT1 impaired EZH2 recruitment to its target loci and upregulated expression of EZH2 repressed genes. Further studies indicated that MALAT1 plays a vital role in EZH2-enhanced migration and invasion in CRPC cell lines. Meta-analysis and RT-qPCR of patient specimens demonstrated a positive correlation between MALAT1 and EZH2 expression in human CRPC tissues. Finally, we showed that MALAT1 enhances expression of PRC2-independent target genes of EZH2 in CRPC cells in culture and patient-derived xenografts. Together, these data indicate that MALAT1 may be a crucial RNA cofactor of EZH2 and that the EZH2- MALAT1 association may provide a new avenue for development new strategies for treatment of CRPC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.5728

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Wang, D., Ding, L., Wang, L., Zhao, Y., Sun, Z., Karnes, R. J., Zhang, J., & Huang, H.
Venue
Oncotarget
Published
2015-10-15
Volume
6
Issue
38
Pages
41045-41055
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2269628271
Cited by
184
References
2
FWCI
7.65
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.